Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 24-May-2018

Hurd Health Group

Abstract

Hurd Health Group is a Biotech startup that is bringing the next generation of LVAD (left ventricle assist device) to the market. SymVitae is an innovative cardiac assist device which uses a novel drive system to assist the heart in contracting naturally. SymVitae is for 70,000 people a year that suffer from heart failure.

Video

Additional Questions

Who is your customer?

Our customers are those suffering from heat failure and heart defects, specifically those who receive a heart assist device. Every year approximately 5,000 adults and 3,000 babies receive heart assist devices. Also, annually 70,000 Americans could benefit from a better heart assist device but do not have a lower risk option available to them. These populations are our customers because the have the most to gain from our technology.